Avian influenza vaccine {#cesec10}
=======================

The [A/H7N9](http://dx.doi.org/10.1126/scitranslmed.3008761){#interrefs10} avian influenza strain that emerged in China in 2013 could initiate a lethal influenza pandemic if it acquires the ability to spread between people. Researchers now report that a vaccine produced by cell culture from a synthetic A/H7N9 seed virus is immunogenic in adults. In a phase 1 study of 402 healthy adults, vaccine formulations with and without adjuvant were well tolerated and induced effective immune responses in individuals without pre-existing immunity to the strain. These findings bring the development of a vaccine that could be rapidly produced in the event of an A/H7N9 pandemic a step closer.

MERS coronavirus antibodies {#cesec20}
===========================

There are currently no licensed vaccines or antiviral drugs that provide protection against or can be used to treat Middle East respiratory syndrome (MERS) coronavirus infections. Now, two studies have identified nine human neutralising antibodies to this emerging and lethal virus. In both [studies](http://dx.doi.org/10.1073/pnas.1402074111){#interrefs20}, the antibodies were isolated from a non-immune human antibody library. The antibodies, which were all against the receptor-binding domain of the MERS coronavirus spike glycoprotein, are promising candidates for the development of prophylactic and therapeutic interventions against the virus.
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Childhood tuberculosis test {#cesec30}
===========================

The diagnosis of childhood [tuberculosis](http://dx.doi.org/10.1056/NEJMoa1303657){#interrefs30} is usually made on clinical grounds because sputum smears and cultures are rarely positive for *Mycobacterium tuberculosis* in children. However, clinical diagnosis of childhood tuberculosis is unreliable because several other disorders have similar signs and symptoms. A study that examined gene transcript patterns in South African and Malawian children with suspected tuberculosis has identified a 51-transcript signature that distinguishes tuberculosis from other diseases. In a validation cohort of 1599 Kenyan children, the signature had a sensitivity of 82·9% and a specificity of 83·6% for the diagnosis of culture-confirmed tuberculosis.

Biodiversity and zoonoses {#cesec40}
=========================

Are recent increases in the incidence of [zoonotic diseases](http://dx.doi.org/10.1073/pnas.1404958111){#interrefs40} linked to declines in populations of large wild animals? To test the hypothesis that such defaunation might release controls on the density of the rodent populations that are the reservoirs for the flea-borne human zoonotic pathogen *Bartonella,* researchers excluded large wildlife from a savannah ecosystem in east Africa and monitored the rodent and flea populations. The abundance of rodents and fleas increased after defaunation but the proportions of both the flea and rodent populations that were infected with *Bartonella* remained constant. Thus, defaunation might increase the risk of transmission of *Bartonella* and other zoonotic pathogens to people, and effective conservation might moderate some emerging threats to public health.

*Bordetella pertussis* evolution {#cesec50}
================================

An analysis of the genomes of 343 isolates of [*Bordetella pertussis*](http://dx.doi.org/10.1128/mBio.01074-14){#interrefs50} collected from around the world over the past 100 years provides new insights into the emergence of this pathogen and its adaptation to vaccination. The global phylogeny suggests that whooping cough emerged within the past 500 years and that the spread of new strains is very rapid. The analysis also implicates several classes of genes in the pathogen\'s adaptation to vaccination and suggests ways to improve pertussis vaccines.

Leishmaniasis vaccine {#cesec60}
=====================

Effective immunity against leishmaniasis depends on cellular immune responses. Researchers now report that they have developed a DNA vaccine that induces [T-cell-based](http://dx.doi.org/10.1126/scitranslmed.3008222){#interrefs60} immunity and that is, therefore, a candidate for clinical trials. The researchers selected antigens that are conserved in several *Leishmania* species and expressed them in a second-generation DNA vector that is optimised for T-cell induction. The DNA constructs induced CD4 and CD8 T-cell responses in cells isolated from genetically diverse human populations, and a modular multi-antigen DNA vaccine was protective in a mouse model of infection.

Tsetse fly genome unzipped {#cesec70}
==========================

The International Glossina Genome Initiative has sequenced and annotated the 366-megabase genome of [*Glossina morsitans morsitans*](http://dx.doi.org/10.1126/science.1249656){#interrefs70}, the sole vector of African trypanosomiasis in sub-Saharan Africa. The genome, which includes 12 308 predicted protein-encoding genes, contains some of the chromosomes of the bacterium *Wolbachia*, a symbiont that tsetse flies rely on for nutrients not present in their blood meals, and the genes needed to make the milk-like secretion on which tsetse flies feed their live-born young. These and other findings should help with research into ways to prevent trypanosomiasis by providing new insights into tsetse fly biology.

For more on **human neutralising antibodies against MERS coronavirus** see *Sci Transl Med* 2014; **6:** 234ra61
